Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 11 /hr
Hire Dr. Anbarasu K.
USD 11 /hr
Profile Summary
Subject Matter Expertise
Work Experience

Research Fellow

University of Michigan Hospital

January 2020 - Present


PhD (Biotechnology)

Indian Institute of Technology Madras

July 2009 - September 2019

MSc (Biotechnology)

Bharathiar University

2007 - 2009

BSc (Biotechnology)

PSG College of Arts and Science

2004 - 2007

Diploma in Diagnostics & Clinical Laboratory Management (Biochemistry)

PSG College of Arts and Science

2004 - 2006

  • Certification details not provided.
Kim, Dae-Hwan, Sun, Duanchen, Storck, William K, Welker Leng, Katherine R, Jenkins, Chelsea, Coleman, Daniel J, Sampson, David A, Guan, Xiangnan, Kumaraswamy, Anbarasu, Rodansky, Eva S, et al. (2021). BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program . Clinical Cancer Research.
Kumaraswamy, Anbarasu, Leng, Katherine R. Welker, Westbrook, Thomas C., Yates, Joel A., Zhao, Shuang G., Evans, Christopher P., Feng, Felix Y., Morgan, Todd M., Alumkal, Joshi J. (2021). Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer . European Urology.
Coleman, Daniel J., Sampson, David A., Sehrawat, Archana, Kumaraswamy, Anbarasu, Sun, Duanchen, Wang, Yuzhuo, Schwartzman, Jacob, Urrutia, Joshua, Lee, Ahn R., Coleman, Ilsa M., et al. (2020). Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4 . Neoplasia.
Ananthi, S., Lakshmi, C.N.P., Atmika, P., Anbarasu, K., Mahalingam, S.(2018). Global Quantitative Proteomics reveal Deregulation of Cytoskeletal and Apoptotic Signalling Proteins in Oral Tongue Squamous Cell Carcinoma . Scientific Reports. 8. (1).
Kumaraswamy, Anbarasu and Mamidi, Anitha and Desai, Pavitra and Sivagnanam, Ananthi and Perumalsamy, Lakshmi Revathi and Ramakrishnan, Chandrasekaran and Gromiha, Michael and Rajalingam, Krishnaraj and Mahalingam, Sundarasamy(2018). The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function . Journal of Biological Chemistry. 293. (40). p. 15691-15705.
Kowshik, J., Mishra, R., Sophia, J., Rautray, S., Anbarasu, K., Reddy, G.D., Dixit, M., Mahalingam, S., Nagini, S.(2017). Nimbolide upregulates RECK by targeting miR-21 and HIF-1α in cell lines and in a hamster oral carcinogenesis model . Scientific Reports. 7. (1).
Datta, D. and Anbarasu, K. and Rajabather, S. and Priya, R.S. and Desai, P. and Mahalingam, S.(2015). Nucleolar GTP-binding protein-1 (NGP-1) promotes G1to S phase transition by activating cyclin-dependent kinase inhibitor p21Cip1/Waf1 . Journal of Biological Chemistry. 290. (35). p. 21536-21552.
Thoompumkal, I.J., Rao, M.R.K.S., Kumaraswamy, A., Krishnan, R., Mahalingam, S.(2015). GNL3L is a nucleo-cytoplasmic shuttling protein: Role in cell cycle regulation . PLoS ONE. 10. (8).
Suryaraja, R., Anitha, M., Anbarasu, K., Kumari, G., Mahalingam, S.(2013). The E3 ubiquitin ligase itch regulates tumor suppressor protein RASSF5/NORE1 stability in an acetylation-dependent manner . Cell Death and Disease. 4. (3).
Boddapati, N., Anbarasu, K., Suryaraja, R., Tendulkar, A.V., Mahalingam, S.(2012). Subcellular distribution of the human putative nucleolar GTPase GNL1 is regulated by a novel arginine/lysine-rich domain and a GTP binding domain in a cell cycle-dependent manner . Journal of Molecular Biology. 416. (3). p. 346-366.